A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in users administering substances of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the platform has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of joining one group, a vendor shared contact information, where the majority of purchases take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, posts show dark colored packages with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these online products may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially serious medical dangers”.
